Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients

Tumour Biol. 1998;19(6):464-9. doi: 10.1159/000030038.

Abstract

The relationship between preoperative serum carcinoembryonic antigen (CEA), CA 19-9 and alpha-fetoprotein (AFP) levels and their clinicopathological features were evaluated in gastric cancer patients. The positive rates of CEA, CA 19-9 and AFP were 24.8, 27.6 and 12.7%, respectively. Gastric cancer with deeper tumor invasion was significantly more common among patients positive for these tumor markers. Patients with positive CEA or CA 19-9 values had a significantly high risk of lymph node metastases (p = 0.045 and p = 0.002, respectively). Synchronous liver metastases was more commonly found in patients with a positive CA 19-9 value. A significant difference (p < 0.001) in survival rate was found between patients with positive CA 19-9 values and those with negative values. CA 19-9 is useful for the prognosis of gastric cancer patients, whereas CEA, although unsuitable for prognosis, contributes to the prediction of cancer invasion.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • CA-19-9 Antigen / blood*
  • Carcinoembryonic Antigen / blood*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Stomach Neoplasms / blood*
  • Stomach Neoplasms / pathology
  • alpha-Fetoproteins / analysis*

Substances

  • CA-19-9 Antigen
  • Carcinoembryonic Antigen
  • alpha-Fetoproteins